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The increase in capillary vessel density observed in
neoplastic processes is an occurrence that has been
argued and speculated upon recently. The question is
whether it is a result of neoplasia or is an important
critical factor in the pathogenesis of the neoplasia.
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The aim of this study was to evaluate the effect of chronic inflammatory pathology on the angio-
genic activity in benign prostatic hyperplasia (BPH). Besides the presence of a relationship between
serum prostate specific antigen (PSA) values and microvessel density (mvd), the intensity and extent
(widespread or focal) of tissue PSAexpression was also examined. The distribution of 30 cases accord-
ing to the diagnosis groups was as follows: group 1, nine cases with prostatic adenocarcinoma;
group 2, 10 cases with BPH and chronic prostatitis; group 3, 11 cases with BPH. The biopsy materials
obtained by tru-cut biopsy (five cases) and transurethral resection (25 cases) were evaluated retro-
spectively. The evaluation of angiogenesis was made by CD34 immune marker, while the analysis
of immunohistochemical tissue PSA expression was verified by PSA immune marker. Serum PSA
levels and other clinical parameters were obtained from the clinical files of the patients. The mean
age of the patients was 68±3 years (range, 48–83 years). The difference between the mean mvd values
of the groups was statistically significant (χ2 =10.492, p=0.005). Group 1 showed higher mean mvd
value than the other two groups. Although group 2 showed higher mean mvd value than group 3,
the difference was not statistically significant (p=0.863). There was no correlation between the
mean mvd and serum PSA levels in any group. The intensity of PSA expression in prostate speci-
mens was different in all groups. Maximum cases in group 3 showed high tissue PSA expression
(χ2 =12.442, p=0.014). In group 1, there was a significant relationship between the intensity of PSA
expression and the mean mvd (U=1, p=0.032). In group 2, a statistically significant correlation was
noted between the mean serum PSA levels and the widespread occurrence of PSA expression
(U=0, p=0.017). In the present study, we determined that chronic prostatitis had no effect on mvd
in BPH cases. The correlation between tissue PSA expression and mvd was contradictory to the
reports in the literature. Analyses in larger series are needed to prove the presence of a probable
effect of chronic prostatitis on angiogenesis.
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The values of microvessel density (mvd) determined
in malignant neoplasms are considerably higher than
those in benign neoplasms and normal tissues [1].
Many chemical mediators suggested to have a role in
the formation of new capillary vessels exist. Based on
the results of clinical and experimental studies carried
out earlier, it was suggested that some of these medi-
ators were released by inflammatory cells associated
with neoplasia, while the others were produced by
transformed neoplastic cells [2–4].
The effect of chronic inflammation on the patho-
genesis of neoplasia has been argued for a long time
and is suggested to be an important factor in the patho-
genesis of some neoplasms. Inflammatory pathology,
which accompanies some epithelial malignant tumors,
is now accepted to play an important role in the devel-
opment and progression of malignancy via autocrine
and paracrine factors released by the inflammatory
cells. A part of this role was suggested to be created
via the stimulation of angiogenesis [4].
Although an organ-specific hormone prostate spe-
cific antigen (PSA) is determined in high serum lev-
els in patients with prostate carcinoma, serum PSA
levels also reach higher values in benign prostatic
hyperplasia (BPH), chronic prostatitis (CP), and after
the biopsy procedure [5–8]. The effect of CP on the
serum PSA level causes problems of differential diag-
nosis in prediagnosis of prostate carcinoma and the
follow-up postoperative care of patients with prostate
carcinoma. The studies which investigated the proba-
ble relationship between serum PSA level and angio-
genic activity are present in the literature [9,10].
In this study, we investigated the correlation be-
tween inflammatory process and mvd, serum PSA
level, and tissue PSA expression in cases of BPH with
and without CP and prostate carcinoma.
MATERIALS AND METHODS
Transurethral resection (TUR) and tru-cut biopsy mate-
rial of 30 cases were evaluated in the study. Five 
of these cases were tru-cut needle biopsy, while 25
cases’ tissue specimens consisted of TUR material. The
distribution of cases according to the histopathologic
diagnoses was as follows: group 1, nine cases with
prostatic adenocarcinoma; group 2, 10 cases with BPH
and CP; group 3, 11 cases with BPH. The presence of
lymphoplasmocytic cell infiltration in stromal areas
was accepted as CP. However, lymphoplasmocytic cell
infiltrations spreading to prostatic acini and ductuli
and abscess formation were also accepted as CP. Five
cases in group 1 were diagnosed by tru-cut needle biop-
sies, while the diagnoses of four cases were reached
via prostate TUR materials. All prostate carcinoma
cases had moderately differentiated prostate adeno-
carcinoma. Gleason score of the cases was between 
4 and 7. All the other cases were diagnosed with
prostate TUR materials.
CD34 antibody was used for analysis of angiogenic
activity in the prostate tissues. The most demonstra-
tive biopsy tissue examples of cases diagnosed as
prostate adenocarcinoma were separately blocked and
immunohistochemical analyses were performed on
these blocks. In BPH cases, the paraffin blocks that con-
tained the most demonstrative tissue fragments were
used for immunohistochemical analysis. The sections
were prepared in 4 µm thickness and standard dewax-
ing process was performed after incubation at 37°C
for one night. Subsequently, antigen retrieval pro-
cessing was done in citrate tampon solution using 
a microwave oven. CD34 (monoclonal, QBEnd/10,
1/100, NeoMarkers) and PSA (polyclonal, 1/200,
NeoMarkers) antibodies were applied by using the
streptavidin-peroxidase method. The vessels away
from the tumor and hyperplasia focus served as an
internal positive control for CD34 antibody. Benign
prostate tissues were used as positive control for PSA
antibody. To evaluate angiogenic activity in prostate
tissue stained with CD34, all capillary vessels, endothe-
lial cells, and buds were counted (Figure 1). Middle
and large vascular structures were disregarded. The
capillary vessels and endothelial buds in all tumor
tissues of prostatic carcinoma cases, which were diag-
nosed by tru-cut needle biopsy materials were counted.
In prostate TUR materials, the most demonstrative 10
high-power fields in prostate tissues with tumor were
designated for the capillary vessel counting. If tumor
focus was limited to a smaller area than in the 10 high-
power fields, all tumor areas were included for the
analysis. The area of tumor was calculated in mm2
with ocular grid in tru-cut needle biopsy materials.
In TUR materials, the sum of microvessels counted in
40×power (0.196mm2, Nikon E600) and the number of
counted tissue areas was taken into account and then
mvd was calculated. For the evaluation of PSA
expression in the prostate tissues, the extent of PSA
expression was classified into widespread and focal;
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the intensity of staining into low (1+), intermediate
(2+), and high (3+) were independently evaluated
(Figure 2). Positive staining values ≥ 30% in the most
demonstrative areas of the prostate parenchyma tissue
examined were accepted as widespread PSA staining
and the lower values were regarded as focal PSA
staining.
Serum PSA levels were obtained from the clinical
files of the patients. Only those serum PSA levels that
were measured before the prostate biopsy procedure
were considered for the analyses and the normal
accepted range of serum PSA level was 0–4 ng/mL.
Kruskal-Wallis variants analysis, Mann–Whitney U
test with Bonferonni correction, and χ2 tests (likelihood
ratio) were used for the statistical analysis. The p value
< 0.05 was accepted as significant.
RESULTS
The patients’ ages ranged from 48 to 83 years. The mean
age was 68 ± 3 years. The mean ages and age ranges
according to diagnosis groups were as follows: group
1, 70.7 years and 64–79 years; group 2, 67.2 years and
50–83 years; group 3, 66.5 years and 48–80 years.
The comparison between the groups was made by
Mann–Whitney U test with Bonferonni correction as
the difference between the groups was significant for
mean mvd (χ2 = 10.492, p = 0.005). The mean mvd val-
ues and serum PSA levels for all groups are given in
Table 1. The differences between group 1 and group 2,
and group 1 and group 3 were significant (U = 11,
p = 0.004 and U = 12, p = 0.003). The difference between
group 2 and group 3 was statistically insignificant
BA
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Figure 1. (A) Capillary vessel network observed, especially near the basal membranes of acinar structures in benign prostatic hyper-
plasia (BPH) (CD34, 10×). (B) Middle and capillary vessels at the periphery of and within lymphocytic infiltration area in BPH with
chronic prostatitis (CD34, 20×). (C) Prostatic carcinoma with high density of intratumoral capillary vessel network (CD34, 20×). 
(D) High capillary vessel density observed in stromal infiltration area in another case of prostatic carcinoma (CD34, 25×).
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(U = 52, p = 0.863). The difference between mean PSA
values of group 1 and other groups was not statisti-
cally significant (χ2 = 5.262, p = 0.072) because the dis-
tribution of serum PSA levels of patients in group 1
was not homogeneous. In group 1, the lowest value
for serum PSAwas 2.17ng/mL, while the highest value
was 813 ng/mL. A correlation between the mean mvd
and serum PSA levels was not determined in each
group and between groups. The positive correlation
in group 2 was not significant (p = 0.216).
When the intensity of PSA expression was evalu-
ated, a statistically significant difference between the
groups was found (χ2 = 12.442, p = 0.014) (Table 2).
The eight cases (72.7%) in group 3 showed high PSA
expression. The other three cases (27.3%) of this group
had intermediate PSA expression. There was no sig-
nificant difference between the groups for the extent
of PSA expression (χ2 =0.479, p=0.789) (Table 3).
In all groups, the presence of a probable relation
between mvd, intensity, and extent of PSA expression
and serum PSA levels was investigated with Mann–
Whitney U test.
In group 1, the mean mvd according to the inten-
sity of PSA expression showed significant difference
(U=1, p=0.032). The mean mvd of cases, which showed
low PSA expression was lower than that of cases which
showed high PSA expression. When the means of
serum PSA levels according to the distribution of PSA
expression were evaluated, the difference was not sta-
tistically significant, although the cases which showed
low PSA expression had higher mean serum PSA levels
than those cases which showed high PSA expression
(U = 8, p = 0.73).
In group 2, although higher mean mvd value was
determined in cases which showed high PSA expres-
sion, the difference was statistically insignificant (U=7,
p = 0.714). In this group also, no significant relation
between serum PSA levels and the intensity of PSA
expression was determined (U=6, p=0.548). The same
correlation between mean mvd and the intensity of
PSA expression was noted in group 3. The cases which
showed intermediate PSA expression had higher mean
mvd values than those with low PSA expression. The
difference was statistically significant (U=0, p=0.012).
BA
C Figure 2. (A) Prostatic carcinoma devoid of prostate specific
antigen (PSA) expression in neoplastic epithelial cells (PSA,
10×). (B) Low and intermediate PSA expression in cytoplasm and
cytoplasmic membranes of neoplastic acinar structures in prosta-
tic carcinoma (PSA, 20×). (C) Strong and diffuse cytoplasmic
PSA expression in infiltrating malignant cells in another case of
prostatic carcinoma (PSA, 20×).
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In group 3, no significant correlation between the
intensity of PSA expression and serum PSA levels was
found (U = 9, p = 0.630).
A correlation between the extent of PSA expression
and the other two parameters (mean mvd and serum
PSA value) was not determined in group 1. The U
and p values for the extent of PSA expression and
mvd were 4 and 0.5, respectively, while these values
for the extent of PSA expression and serum PSA levels
were 6 and 0.889, respectively.
A significant relationship was observed between
the mean serum PSA level and the extent of PSA
expression in group 2. The mean serum PSA level of
cases which showed widespread PSA expression was
higher than that of cases which showed focal expres-
sion. The difference was statistically significant (U = 0,
p = 0.017). In this group, a significant relation between
the extent of PSA expression and the mean mvd were
not determined (U = 8, p = 0.667).
In group 3 too, a significant relationship between
the extent of PSA expression, the mean mvd, and serum
PSA levels were not determined (U = 10, p = 0.527;
U = 11.5, p = 0.648).
DISCUSSION
The effect of angiogenesis on development of neo-
plasia is a popular research subject, which has been
extensively investigated in malignant and benign
neoplasms. In the literature, it is frequently reported
that especially malignant neoplasms have high 
capillary vessel density. Whether angiogenesis is an
Table 1. Distribution of mean microvessel density (mvd) and serum prostate specific antigen (PSA) values according
to groups
n Mean value Range p and U
MVD
Group 1 9 163.7 14–233.6 Group 1–group 2; U = 11, p = 0.004*
Group 2 10 85.6 56.1–123 Group 1–group 3; U = 12, p = 0.003*
Group 3 11 81.6 33.6–121 Group 2–group 3; U = 52, p = 0.863*
Total 30 107.6 14–233.6
Serum PSA (ng/mL)
Group 1 9 118.9 2.17–813
Group 2 10 16.3 1.5–42.5 χ2 = 5.262, p = 0.072†
Group 3 11 8.9 1.08–26.5
Total 30 44.4 1.08–813
*Mann–Whitney U test; †Kruskal-Wallis test.
Table 2. Distribution of tissue prostate specific antigen (PSA) immunostaining intensity according to groups 
Immunostaining
Low (1+) PSA Intermediate (2+) PSA High (3+) PSA p
n (%) n (%) n (%)
Group 1 5 (55.6) 0 4 (44.4)
Group 2 3 (30.0) 1 (10.0) 6 (60.0) χ2 = 12.442, p = 0.014
Group 3 0 3 (27.3) 8 (72.7)
Total 8 (26.7) 4 (13.3) 18 (60.0)
Table 3. Distribution of extent of prostate specific antigen
(PSA) immunostaining according to groups
Extent of immunostaining
Focal PSA Widespread PSA p
n (%) n (%)
Group 1 2 (22.2) 7 (77.8)
Group 2 3 (30.0) 7 (70.0) χ2 =0.479,
Group 3 4 (36.4) 7 (63.6) p = 0.789
Total 9 (30.0) 21 (70.0)
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outcome of neoplasia or is a factor which triggers neo-
plasia development is still debated. It is suggested
that various factors stimulate angiogenesis and these
angiogenic factors are released by malignant neo-
plastic cells [11–15]. In some studies, it is suggested
that angiogenic factors with tumor necrosis factor and
basic fibroblastic growing factor are released together
by macrophages [12,13,16]. It has been speculated that
the effect of chronic inflammation on tumorigenesis
could be via stimulating angiogenesis or both factors
could be effective via synergic interaction.
Serum PSA values that are used as an important
parameter in the early diagnosis and clinical follow-
up of prostatic carcinomas could also be increased to
higher levels than normal in BPH and CP [5–8]. The
deterioration of cellular mechanisms is suggested to
be the cause of elevation in serum PSA levels in BPH
and prostatic carcinomas [9]. PSA, which is released
to the extracellular area as a result of this deterioration,
enters into the systemic circulation via local micro-
circulation [9]. Although the release of PSA in sys-
temic circulation has not been understood well, the
increase in the density of capillary vessel network
near the basal layer of prostate ductuli and acini could
be accepted as a facilitative factor for the release of
PSA into the systemic circulation [9]. The effect of
capillary vessel density on serum PSA level has not
been precisely explained [17,18]. However, the results
of an in vitro investigation revealed that PSA converts
plasminogen to biologically active angiostatin-like
fragments. Authors suggested that these fragments
similar to angiostatin would be able to suppress angio-
genesis and, therefore, also tumor growth and tumor
metastasis [19]. In the study by Papadopoulos et al
[10], it was found that high PSA expression by prostate
cancer cells was accompanied by low intratumoral
angiogenesis. The relation between high PSA expres-
sion and low intratumoral angiogenesis seems to be
correlated with the finding that poorly differentiated
prostate cancer expresses significantly less PSA than
benign prostate and low-grade prostate cancer [20,21].
In our study, a statistical difference for the mean
mvd values was not observed between group 2 and
group 3. The differences in the mean mvd between
group 1 and the other two diagnosis groups (group 2
and group 3) were statistically significant (U = 11,
p = 0.004; U = 12, p = 0.003). This was an expected find-
ing but was not the aim of investigation in the pres-
ent study because many studies have revealed that
prostate carcinomas have higher values of mvd than
BPH, prostatic intraepithelial neoplasia, and benign
prostate tissues [22–25].
The effect of chronic inflammation on angiogene-
sis is suggested to occur via some autocrine and
paracrine factors released by macrophages [16]. For
this reason, it has been speculated that the capillary
vessel density value in cases of BPH accompanied by
chronic inflammatory pathology could be of a higher
value than that of the cases with BPH without CP. In
the present study, although the mean mvd value for
the group of BPH with CP was higher than that of the
BPH-without-CP group, the difference was not statis-
tically significant. According to a view, the increase in
serum PSA level in prostate inflammations could be
due to structural and metabolic deterioration of acinic
epithelial cells. In addition to this opinion, another
hypothesis was also suggested that the increased cap-
illary vessel density near the basal layer of the acini
observed in BPH and especially prostate carcinoma
could contribute to increased systemic circulation of
escaped PSA [9]. Some other studies, which analyzed
the effect of capillary vessel density on serum PSA
level, did not prove such a relation [17,18]. In the pres-
ent study, although serum PSA level and the mean
mvd value in cases of BPH with CP were higher than
those of BPH cases, the differences for both these
parameters were not statistically significant.
The difference in the intensity of PSA expression
between groups was clearly observed. The highest
intensity of PSA expression was observed in two cases
of group 3. When a probable relationship between
the mean mvd and the intensity of PSA expression
was analyzed in group 1, it was determined that the
mean mvd value of the cases which showed low PSA
expression was lower than the mean mvd value of
prostate carcinoma cases which showed high PSA
expression (U = 1, p = 0.032). This finding was not con-
cordant with the results of Papadopoulos et al [10].
According to their study, high expression of PSA in
prostate carcinoma was related to low intratumoral
angiogenesis. In the present study, group 1 showed
lower intensity of PSA expression than group 2 and
group 3. This was an expected finding according to
the literature [20,21]. But the correlation between mvd
and PSA expression intensity in group 1 was contrary
to the results of Papadopoulos et al [10]. A similar
relationship between mvd and PSA expression inten-
sity was also determined in group 2 and group 3.
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This reserve correlation that was determined between
mvd and PSA expression in the present study may
result from a small number of cases in the groups.
There was no significant relation between the
intensity of PSA expression and serum PSA levels in
all groups. When the relationship between the extent
of PSA expression and serum PSA levels was ana-
lyzed, it was found that a statistically significant cor-
relation existed between both parameters in group 2.
The mean serum PSA level of cases which showed
widespread PSA expression was significantly higher
than that of cases which showed focal PSA expression
(U = 0, p = 0.017). We can consider that this finding was 
also contrary to the concerned literature data because
widespread PSA expression may be related to lower
mvd and, therefore, the release of PSA into the systemic
circulation may occur at a lower rate [9,17,18,20,21].
Today, it is still not clear whether the increase in
capillary vessel density is a consequence or a cause in
the tumorigenesis process. A view widely accepted 
is that some angiogenic factors released by neoplastic
cells are effective in angiogenesis. However, the angio-
genic effects of secondary pathologies such as inflam-
mation could not be clarified yet. Also, the effects of
similar factors on the serum levels of some hormone
or hormone-like markers used in clinical follow-up
of neoplastic diseases could not be clearly explained.
In our study, we could not show that chronic inflam-
matory pathology has a positive effect on capillary
vessel density in the cases of BPH. Additionally, a
relationship between serum PSA level and mean mvd
was also not observed according to the results of our
study. Analyses of larger series of patients are needed
to reveal a probable relationship between chronic
inflammatory pathology and capillary vessel density.
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